Trade Ideas

Actionable trade ideas with defined risk and time horizons.

Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.

Articles

10,853 total articles

Zevia: Cheap Multiples, Quiet Demand - A Tactical Long with Guardrails

Zevia: Cheap Multiples, Quiet Demand - A Tactical Long with Guardrails

Zevia (ZVIA) is trading at bargain multiples relative to its reported sales and carries a clean balance sheet and positive free cash flow. The market has punished the stock into low-single-digit territory despite a favorable functional-beverage backdrop. This trade idea targets a mid-term rebound to $2.40 while keeping a tight stop under the 52-wee…

Ruger: Debt-Free, Cash-Generating, and a Cheap Play on Heritage Firearms

Ruger: Debt-Free, Cash-Generating, and a Cheap Play on Heritage Firearms

Sturm, Ruger (RGR) is a compact, cash-generative firearms manufacturer trading at roughly $593M market cap with no debt, positive free cash flow, and a modest dividend. After a rough earnings print, the market has punished the stock to a level that, in our view, understates Ruger’s balance-sheet strength and growth optionality from new products and…

Kaspi.kz: Buy the Franchise, Back the Turkey Upside

Kaspi.kz: Buy the Franchise, Back the Turkey Upside

Kaspi.kz (KSPI) runs a tightly integrated payments-marketplace-fintech ecosystem with durable network effects and cash-generative operations. At a $17.1B market cap, 8.5x trailing P/E and a 3.8% yield, the stock offers a beaten-up multiple with a clear catalyst set: dividend support, Turkish expansion via the Rabobank A.Ş. deal, and steady domestic…

AdvanSix Faces Prolonged Cyclical Pain - Tactical Short Setup at $16.75

AdvanSix Faces Prolonged Cyclical Pain - Tactical Short Setup at $16.75

AdvanSix (ASIX) is a small-cap specialty chemicals maker whose nylon, caprolactam and plant-nutrients businesses are under pressure from weak end markets. Fundamentals show declining sales and negative free cash flow, while technicals and short interest point to continued selling. I am recommending a tactical short entry at $16.75 with a mid-term h…

Algonquin Power: Q2 Momentum Sets Up a Measured Swing Long

Algonquin Power: Q2 Momentum Sets Up a Measured Swing Long

Algonquin Power & Utilities (AQN) looks set for a mid-term swing as the company’s transition to a regulated-only profile stabilizes cash flow and supports a 4.6% yield. Market cap of $4.55B, a PB near 1.02 and recent technicals near support make a disciplined long with a clear stop and a target at the 52-week high a pragmatic trade.

Boeing: Buy Ahead of a 2027 Cash-Flow Inflection

Boeing: Buy Ahead of a 2027 Cash-Flow Inflection

Boeing is positioned to convert certification and backlog into cash flow over the next 12-18 months. The FAA's 737 MAX 7 approval and fresh defense awards create a near-term catalyst mix, while improving production and strong travel demand underpin a steady revenue base. Valuation is rich on trailing multiples, but the risk/reward favors a tactical…

Palantir: Growth Is Real — Time to Trade the Re-rating

Palantir: Growth Is Real — Time to Trade the Re-rating

Palantir delivered a blowout Q2 (93% revenue growth) and guidance lift, and the stock is re-rating as investors rotate into software from chips. The business combines sticky government contracts with accelerating commercial AI wins — a combination that supports a premium multiple. This trade targets continued multiple expansion into $200+ territory…

TAT Technologies: Operational Recovery Sets Up a Tactical Long Trade

TAT Technologies: Operational Recovery Sets Up a Tactical Long Trade

TAT Technologies (TATT) looks to be stabilizing after a rocky first quarter. Solid Q2 2025 results, a $523M market cap, and improving MRO demand underpin our bullish trade idea. We outline an actionable entry at $39.50, a $34.50 stop, and a $55.00 target over a mid-term (45 trading days) horizon, with clear risk triggers and what would change our v…

Roivant: Cash-Rich Optionality Makes This a Tactical Long

Roivant: Cash-Rich Optionality Makes This a Tactical Long

<p>Roivant (ROIV) is trading within striking distance of its 52-week high while sitting on a balance sheet that looks more like a strategic toolkit than a simple war chest. The company reported roughly $4.4B in cash and effectively no debt, giving management real optionality to fund late-stage programs, pursue tuck-in acquisitions, or return capita…

Idexx Laboratories: Pay Up for Durable Diagnostics Growth

Idexx Laboratories: Pay Up for Durable Diagnostics Growth

Idexx (IDXX) is a high-quality diagnostics business with recurring revenue, industry-leading margins and accelerating diagnostic frequency. Recent results and raised guidance support continued top-line momentum. The stock trades at a premium, but fundamentals and cash generation make a disciplined long trade attractive over a 180 trading-day horizo…

B2Gold: Temporary Goose Headwind — A Re-Rating Trade Setup

B2Gold: Temporary Goose Headwind — A Re-Rating Trade Setup

B2Gold's fire at the Goose crushing circuit is a definable, contained hit to Q2 output but does not change the company's cash-generation profile or strategic progress. Use a disciplined, mid-term long trade that leans on de-risking from the Fingold sale, robust production last year and heavy intraday flows that can fuel a continuation move.

Microsoft at the Helm of the AI Cycle - Buy and Hold for the Long Run

Microsoft at the Helm of the AI Cycle - Buy and Hold for the Long Run

Microsoft is trading near $500 after an extended run, but the core business - cloud, Office, LinkedIn and a growing AI platform - still generates predictable cash flow and profitable growth. At a market cap north of $3.7 trillion and free cash flow near $67B, Microsoft remains a buy-and-hold anchor with room to compound over the next 180 trading da…